Paper Details
- Home
- Paper Details
Identification and management of contraindicated drug-drug interactions through pharmaceutical care programs: Experience in direct-acting antivirals therapy.
Author: ChenYen-Chun, ChuYa-Lan, KuoMeng Hsuan, LeeChi-Hui, LinHsiu-Ju, TsengChih-Wei, TsengKuo-Chih, WuHsin-Ju, YangYa-Ching
Original Abstract of the Article :
BACKGROUND/PURPOSE: To investigate the impact of pharmaceutical care programs for the management of contraindicated drug-drug interactions (DDIs) in direct-acting antivirals (DAAs) therapy. METHODS: A prospective observational study was performed at Dalin Tzu Chi Hospital between January 2018 and D...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.jfma.2021.01.008
データ提供:米国国立医学図書館(NLM)
Pharmaceutical Care: Guiding Patients Through the Desert of Drug Interactions
Imagine a vast desert of medications, each with its own unique properties and potential interactions. Navigating this landscape can be challenging, especially for patients taking multiple medications. This research explores the role of pharmaceutical care programs in identifying and managing contraindicated drug-drug interactions (DDIs) in patients receiving direct-acting antivirals (DAAs) for hepatitis C.
The study found that pharmacists played a crucial role in identifying DDIs, particularly in patients taking statins or amiodarone. They were able to intervene and provide recommendations to physicians, leading to adjustments in medication regimens and potentially preventing adverse drug events (ADEs). The study also highlighted the significant cost avoidance associated with these pharmaceutical care programs.
This study demonstrates that pharmaceutical care programs can significantly improve patient safety by proactively identifying and managing DDIs. It highlights the importance of involving pharmacists in medication management, particularly in complex treatment regimens like DAA therapy.
Finding a Safe Path Through the Desert of DDIs
This research underscores the importance of comprehensive medication management and the value of involving pharmacists in patient care. Pharmaceutical care programs can help to prevent adverse drug events, improve patient safety, and ensure optimal treatment outcomes.
From the Desert to the Clinic: The Power of Collaboration
This study highlights the benefits of interprofessional collaboration in healthcare. By working together, pharmacists and physicians can create a safer and more effective system for managing medications and improving patient well-being. This research underscores the importance of embracing a team-based approach to patient care and harnessing the expertise of all healthcare professionals involved.
Dr.Camel's Conclusion
This study demonstrates the crucial role of pharmaceutical care programs in ensuring patient safety and optimizing medication management. By proactively identifying and managing DDIs, pharmacists can help patients navigate the complex desert of medications and achieve the best possible outcomes. It's a reminder that collaboration and expertise are essential for providing high-quality healthcare.
Date :
- Date Completed 2021-12-21
- Date Revised 2021-12-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.